Envoy Medical Profit Margin

The latest profit margin for COCH is -11304.83% as of June 2026. That compares with -9579.28% in the prior-year period — down 18.0% year over year. That is below the sector sector average of 13.09%. Investors often review this figure alongside Envoy Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, COCH's profit margin moved from -9579.28% to -11304.83% — a 18.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Envoy Medical's valuation or profitability profile.

Against its sector companies, COCH currently prints -11304.83% for profit margin, while the sector average sits near 13.09%. That is roughly 86472.2% below the sector mean. Large gaps often invite a closer look at Envoy Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Envoy Medical converts resources into returns. At -11304.83%, COCH may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9579.28% in the prior-year period — down 18.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting COCH's profit margin (-11304.83%), review year-over-year change from -9579.28%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.